Wells Fargo & Company »

Neurogene shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $132k 7.6k 17.33
2025-06-30 $95k 6.4k 14.96
2025-03-31 $75k 6.4k 11.71
2024-12-31 $124k 5.4k 22.86
2024-09-30 $170k 4.0k 41.96
2024-06-30 $146k 4.0k 36.39
2024-03-31 $24k 471 50.90
2023-12-31 $8.0k 414 19.38